Servier Pharmaceuticals shared a post on LinkedIn:
“For more than 20 years, Des Murphy has played a key role in Servier’s international journey, navigating diverse roles across Ireland, Asia, the UK, France, and now Boston.
In his new role as U.S. Oncology Assets Liaison, Des leverages his deep oncology expertise and global leadership experience to connect teams and strategies – all with one goal in mind: delivering innovative treatments to patients.
Discover how Des’s passion for science, people, and innovation continues to shape Servier’s oncology mission around the world.
Read the full story here.”
More from Servier Pharmaceuticals on OncoDaily.